Outlook on the Dental Infection Control Products Global Market to 2026 - Featuring Dentisan, Biotrol and Ecolab Among Others
31 janv. 2022 05h48 HE
|
Research and Markets
Dublin, Jan. 31, 2022 (GLOBE NEWSWIRE) -- The "Dental Infection Control Products Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The dental...
Dental Infection Control Products Market Worth $1.6 Billion by 2026 - COVID-19 Draws Attention to Infection Control in Dental Facilities
24 déc. 2021 07h08 HE
|
Research and Markets
Dublin, Dec. 24, 2021 (GLOBE NEWSWIRE) -- The "Dental Infection Control Products - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Dental...
Auris Medical Announces Launch of New Corporate Website
16 juil. 2021 09h00 HE
|
Auris Medical AG
Hamilton, Bermuda, July 15, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection,...
Qu Biologics Receives Additional Funding to Accelerate Clinical Development of Qu’s First-in-Class Immunotherapeutic for COVID-19 Prevention and Treatment
23 juin 2021 08h00 HE
|
Qu Biologics, Inc.
VANCOUVER, British Columbia, June 23, 2021 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a private clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel...
Global Hepatitis C In-Vitro Diagnostics Tests Market Report 2021-2030 Featuring Abbott Laboratories, Siemens Healthineers, Grifols, F. Hoffmann-La Roche, Ortho-Clinical Diagnostics & Hologic
21 avr. 2021 07h18 HE
|
Research and Markets
Dublin, April 21, 2021 (GLOBE NEWSWIRE) -- The "Hepatitis C Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" report has been added to...
Sorrento and Celularity to Initiate Emergency Allogeneic Natural Killer (NK) Cell Therapy Development for Coronavirus Infection
29 janv. 2020 07h00 HE
|
Sorrento Therapeutics, Inc.
SAN DIEGO and WARREN, N.J., Jan. 29, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") announced it has initated a clinical and manufacturing collaboration with...